Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|April 5, 2011
The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell lineNoemi Kedei, Andrea Telek, Alexandra Czap, et al.
The Journal of Biological Chemistry|February 22, 2012
Molecular basis for failure of "atypical" C1 domain of Vav1 to bind diacylglycerol/phorbol esterTamas Geczy, Megan L Peach, Saïd El Kazzouli, et al.
ACS Chemical Biology|February 2, 2013
Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1Noemi Kedei, Nancy E Lewin, Tamás Géczy, et al.
Nature Communications|July 12, 2024
Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppressionSara Zahraeifard, Zhiguang Xiao, Jae Young So, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2012
A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant miceRobert L Kortum, Alexandre K Rouquette-Jazdanian, Michihiko Miyaji, et al.
Science Translational Medicine|July 1, 2026
KSHV-infected endothelial cells expand and up-regulate angiogenic pathways and CXCR4 in patient-derived Kaposi sarcoma modelsXiaofan Li, Zoë Weaver Ohler, Amanda Day, et al.
Science Advances|November 15, 2023
Expression of the transcription factor Klf6 by thymic epithelial cells is required for thymus developmentJustin Malin, Gustavo Ulises Martinez-Ruiz, Yongge Zhao, et al.
Bioorganic & Medicinal Chemistry|May 6, 2014
Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRPLia C Garcia, Lucia Gandolfi Donadío, Ella Mann, et al.
Neuro-Oncology Advances|October 1, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axisSeketoulie Keretsu, Taijun Hana, Alexander Lee, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcomeFabien Bertillot, Solène Hervé, Nelly Drobjazko, et al.
Pageof 8